Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-05-31
2005-05-31
Weber, Jon (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C562S445000, C562S553000
Reexamination Certificate
active
06900179
ABSTRACT:
Disclosed are compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.
REFERENCES:
patent: 4018912 (1977-04-01), Failli et al.
patent: 4018913 (1977-04-01), Okamoto et al.
patent: 4018915 (1977-04-01), Okamoto et al.
patent: 4036955 (1977-07-01), Okamoto et al.
patent: 4041156 (1977-08-01), Okamoto et al.
patent: 4046876 (1977-09-01), Okamoto et al.
patent: 4055636 (1977-10-01), Okamoto et al.
patent: 4055651 (1977-10-01), Okamoto et al.
patent: 4069318 (1978-01-01), Okamoto et al.
patent: 4070457 (1978-01-01), Okamoto et al.
patent: 4071621 (1978-01-01), Okamoto et al.
patent: 4073914 (1978-02-01), Kikumoto et al.
patent: 4074057 (1978-02-01), Kawamatsu et al.
patent: 4096255 (1978-06-01), Kikumoto et al.
patent: 4097591 (1978-06-01), Okamoto et al.
patent: 4104392 (1978-08-01), Okamoto et al.
patent: 4977168 (1990-12-01), Bernat et al.
patent: 5338755 (1994-08-01), Wagnon et al.
patent: 5397801 (1995-03-01), Wagnon et al.
patent: 5481005 (1996-01-01), Wagnon et al.
patent: 5578633 (1996-11-01), Wagnon et al.
patent: 5686628 (1997-11-01), Veale et al.
patent: 6147073 (1995-04-01), None
patent: 2357334 (1974-06-01), None
patent: 2655636 (1977-06-01), None
patent: 0526348 (1993-02-01), None
patent: 9711143.9 (1997-05-01), None
patent: 9714314.3 (1997-07-01), None
patent: 9714316.8 (1997-07-01), None
patent: 9714335.8 (1997-07-01), None
patent: 9722674.0 (1997-10-01), None
patent: 9800680.2 (1998-01-01), None
patent: 9800684.4 (1998-01-01), None
patent: 9800686.9 (1998-01-01), None
patent: 04154732 (1992-05-01), None
patent: WO 92/16549 (1992-10-01), None
patent: WO 94/07815 (1994-04-01), None
patent: WO 94/12181 (1994-06-01), None
patent: WO 95/15973 (1995-06-01), None
patent: WO 96/20725 (1996-07-01), None
patent: WO 96/20949 (1996-07-01), None
patent: WO 96/22966 (1996-08-01), None
patent: WO 97/03094 (1997-01-01), None
patent: 97/03094 (1997-01-01), None
patent: WO 98/04247 (1998-02-01), None
patent: WO 98/42656 (1998-10-01), None
patent: WO 98/53814 (1998-12-01), None
patent: WO 98/53817 (1998-12-01), None
patent: WO 98/53818 (1998-12-01), None
patent: WO 98/54207 (1998-12-01), None
patent: 99/06436 (1999-02-01), None
patent: WO 99/10312 (1999-03-01), None
patent: WO 99/10313 (1999-03-01), None
U.S. Appl. No. 60/022,890, filed Jul. 1996, Lin et al.
U.S. Appl. No. 08/821,825, filed Mar. 1997, He et al.
Simanis et al.,Int. J. Pept. Protein Res.,(1982), 16:(1), pp. 67-70.
Leibritz, et al.,Tetrahedron(1982), 38(14), pp. 2165-2181.
El-Naggar, et al.,Acta. Pharm. Jugosl.,(1985), 35(1), pp. 15-22.
Chemical Abstract No. 126040, vol. 74, No. 23 (Jun. 7, 1971).
Chemical Abstract No. 176262, vol. 99, No. 21 (Nov. 21, 1983).
Chemical Abstract No. 210288, vol. 106, No. 25 (Jun. 22, 1987).
Chemical Abstract No. 167952, vol. 108, No. 19 (May 9, 1988).
Chemical Abstract No. 34164, vol. 125, No. 3 (Jul. 15, 1996).
Ashwell Susan
Baudy Reinhardt Bernhard
Dressen Darren B.
Grant Francine S.
Konradi Andrei W.
Foley & Lardner LLP
Lukton David
Weber Jon
LandOfFree
Carbamyloxy compounds which inhibit leukocyte adhesion... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbamyloxy compounds which inhibit leukocyte adhesion..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbamyloxy compounds which inhibit leukocyte adhesion... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3389441